Ubs Asset Management Americas Inc Wave Life Sciences Ltd. Transaction History
Ubs Asset Management Americas Inc
- $381 Billion
- Q3 2024
A detailed history of Ubs Asset Management Americas Inc transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 144,718 shares of WVE stock, worth $1.95 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
144,718
Previous 171,049
15.39%
Holding current value
$1.95 Million
Previous $853,000
39.04%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding WVE
# of Institutions
164Shares Held
117MCall Options Held
148KPut Options Held
109K-
Ra Capital Management, L.P. Boston, MA18.2MShares$245 Million2.08% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx10MShares$135 Million1.71% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA9.7MShares$131 Million0.15% of portfolio
-
Black Rock Inc. New York, NY6.74MShares$90.8 Million0.0% of portfolio
-
M28 Capital Management LP Stamford, CT6.16MShares$83.1 Million48.05% of portfolio
About Wave Life Sciences Ltd.
- Ticker WVE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,820,096
- Market Cap $1.17B
- Description
- Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...